We are live on ! Find out more
AGN

Allergan plc
AGN

Delisted

AGN was delisted on the 8th of May, 2020.

1,056 hedge funds and large institutions have $96.1B invested in Allergan plc in 2015 Q3 according to their latest regulatory filings, with 121 funds opening new positions, 402 increasing their positions, 407 reducing their positions, and 93 closing their positions.

New
Increased
Maintained
Reduced
Closed

30% more first-time investments, than exits

New positions opened: 121 | Existing positions closed: 93

15% more call options, than puts

Call options by funds: $1.73B | Put options by funds: $1.51B

2% more funds holding

Funds holding: 1,0351,056 (+21)

1% less repeat investments, than reductions

Existing positions increased: 402 | Existing positions reduced: 407

7% less capital invested

Capital invested by funds: $103B → $96.1B (-$7.12B)

11% less funds holding in top 10

Funds holding in top 10: 176157 (-19)

Holders
1,056
Holders Change
+21
Holders Change %
+2.03%
% of All Funds
29.47%
Holding in Top 10
157
Holding in Top 10 Change
-19
Holding in Top 10 Change %
-10.8%
% of All Funds
4.38%
New
121
Increased
402
Reduced
407
Closed
93
Calls
$1.73B
Puts
$1.51B
Net Calls
+$223M
Net Calls Change
+$273M
Name Holding Trade Value Shares
Change
Change in
Stake
QIM
351
Quest Investment Management
Oregon
$13.4M +$3.22M +10,498 +27%
Calamos Advisors
352
Calamos Advisors
Illinois
$13.4M +$266K +867 +2%
Mitsubishi UFJ Asset Management
353
Mitsubishi UFJ Asset Management
Japan
$13.4M +$485K +1,579 +3%
TAM
354
Todd Asset Management
Kentucky
$13.3M -$194K -633 -1%
SM
355
Scoggin Management
New York
$13.2M -$22.5M -73,400 -60%
HCM
356
Highbridge Capital Management
New York
$13M -$7.56M -24,620 -34%
HCM
357
Huber Capital Management
California
$12.9M -$832K -2,710 -5%
TAM
358
Taurus Asset Management
New York
$12.6M +$86.9K +283 +0.6%
DAM
359
Deltec Asset Management
New York
$12.6M -$11M -35,655 -43%
OC
360
Oppenheimer & Co
New York
$12.6M +$67K +218 +0.5%
RPAM
361
Rhenman & Partners Asset Management
Sweden
$12.5M +$1.23M +4,000 +10%
ECM
362
Endurant Capital Management
California
$12.4M -$3.87M -12,600 -22%
LS
363
Livforsakringsbolaget Skandia
Sweden
$12.3M
MRCM
364
M&R Capital Management
New Jersey
$12.3M -$215K -699 -2%
NMERB
365
New Mexico Educational Retirement Board
New Mexico
$12M +$891K +2,900 +7%
GG
366
Gofen & Glossberg
Illinois
$12M +$645K +2,101 +5%
NP
367
NS Partners
United Kingdom
$11.9M -$136K -444 -1%
MTIP
368
Magee Thomson Investment Partners
California
$11.8M +$2.28M +7,430 +21%
JAFL
369
Jay A. Fishman Ltd
Michigan
$11.7M +$1.99M +6,470 +18%
SAM
370
Silvercrest Asset Management
New York
$11.6M -$3.58M -11,652 -22%
CCM
371
Catapult Capital Management
New York
$11.6M +$9.98M +32,500 +325%
KKRC
372
Kohlberg Kravis Roberts & Co
New York
$11.5M +$2.91M +9,476 +29%
NB
373
Norinchukin Bank
Japan
$11.5M +$117K +381 +0.9%
JAM
374
JW Asset Management
Florida
$11.5M +$131K +425 +1%
SMDAM
375
Sumitomo Mitsui DS Asset Management
Japan
$11.4M -$1.8M -5,864 -12%

AGN Hedge Fund Activity: Q3 2015 in Review

1,056 of the 3,583 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN) for Q3 2015, worth a combined $96.1B — down 6.9% from $103B a quarter earlier.

Buyers outnumbered sellers: 121 funds opened new AGN positions and 93 closed out — a net gain of 28 holders — while 402 added to existing stakes and 407 trimmed.

The largest buyer was Norges Bank, opening a new position worth an estimated $1.01B. The largest seller was Fidelity Investments, cutting an estimated $1.45B.

  • 1,056 institutional investors held Allergan plc (AGN) as of Q3 2015, up from 1,035 in Q2 2015.
  • Funds reported $96.1B of Allergan plc stock for Q3 2015, down 6.9% quarter-over-quarter.
  • 121 funds opened new Allergan plc positions in Q3 2015 and 93 closed out, a net change of +28 holders.
  • The largest Allergan plc buyer in Q3 2015 was Norges Bank, an estimated $1.01B added.
  • The largest Allergan plc seller in Q3 2015 was Fidelity Investments, an estimated $1.45B sold.

Based on aggregated 13F filings for Q3 2015.